Antibiotic Prophylaxis in Gynaecologic Procedures

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 4, 2012, Pages 382-391

  Van Eyk, Nancy ^a   van Schalkwyk, Julie ^a   Yudin, Mark H ^a   Allen, Victoria M ^a   Bouchard, Céline ^a   Boucher, Marc ^a   Caddy, Sheila ^a   Castillo, Eliana ^a   Money, Deborah M ^a   Murphy, Kellie E ^a   Ogilvie, Gina ^a   Paquet, Caroline ^a   Senikas, Vyta ^a  

^a NONE   (Canada)

Author keywords

Antibiotics; Gynaecologic surgery; Hysterectomy; Hysteroscopy; Prophylaxis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PIPERACILLIN; VANCOMYCIN;

ABDOMINAL HYSTERECTOMY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; CEPHALOSPORIN ALLERGY; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG HYPERSENSITIVITY; ENDOMETRIUM BIOPSY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; HUMAN; HYSTEROSALPINGOGRAPHY; INCOMPLETE ABORTION; INDUCED ABORTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPIC SURGERY; MISSED ABORTION; NONHUMAN; OBESITY; OBSTETRIC PROCEDURE; PELVIC ORGAN PROLAPSE; PENICILLIN ALLERGY; STRESS INCONTINENCE; URINARY TRACT INFECTION; URODYNAMICS; VAGINAL HYSTERECTOMY; CANADA; FEMALE; GYNECOLOGIC SURGERY; GYNECOLOGY; HYSTERECTOMY; LAPAROSCOPY; MEDICAL SOCIETY; METHODOLOGY; OBSTETRICS; PRACTICE GUIDELINE; TREATMENT OUTCOME;

ANTIBIOTIC PROPHYLAXIS; CANADA; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; GYNECOLOGY; HUMANS; HYSTERECTOMY; HYSTEROSALPINGOGRAPHY; LAPAROSCOPY; OBSTETRICS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84864779034     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35222-7     Document Type: Article

References (56)

1. Zoutman D.E., Ford B.D. A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: pre and post-severe acute respiratory syndrome. Am J Infect Control 2008, 36:711-717.
2. Dancer S.J. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis 2004, 4:611-619.
3. Huskins W.C., Ba-Thike K., Festin M.R., Limpongsanurak S., Lumbiganon P., Peedicayil A., et al. Global Network for Perinatal and Reproductive Health. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet 2001, 73:141-145.
4. Bratzler D.W., Houck P.M., Richards C., Steele L., Dellinger E.P., Fry D.E., et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005, 140:174-182.
5. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999, 27:97-134.
6. Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
7. Bratzler D.W., Houck P.M. Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004, 38:1706-1715.
8. Dellinger E.P., Gross P.A., Barrett T.L., Krause P.J., Martone W.J., McGowan J.E., et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994, 18:422-427.
9. Johnson N, Barlow D, Lethaby A, Tavender E, Curr E, Garry R.Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2006;Issue 2. Art. No.: CD003677. DOI: 10.1002/14651858.CD003677.pub3.
10. Duff P., Park R.C. Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstet Gynecol 1980, 55(5):193-202. Suppl.
11. Cormio G., Vicino M., Loizzi V., Tangari D., Selvaggi L. Antimicrobial prophylaxis in vaginal gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin. J Chemother 2007, 19:193-197.
12. Kauer F.M., Wijma J., Manson W.L. Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharm Weekbl Sci 1990, 12(6A):284-288.
13. Larsson P.G., Carlsson B. Does pre and postoperative metronidazole lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?. Infect Dis Obstet Gynecol 2002, 10:133-140.
14. Tanos V., Rojansky N. Prophylactic antibiotics in abdominal hysterectomy. J Am Coll Surg 1994, 179:593-600.
15. Mittendorf R., Aronson M.P., Berry R.E., Williams M.A., Kipelnick B., Klickstein A., et al. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol 1993, 169:1119-1124.
16. Wttewaall-Evelaar E.W. Meta-analysis of randomized controlled trials of antibiotic prophylaxis in abdominal hysterectomy. Pharm Weekbl Sci 1990, 12(6A):296-299.
17. Cormio G., Di Fazio F., Lorusso F., Di Gesù G., Cacciapuoti C., Loverro G., et al. Antimicrobial prophylaxis in laparotomic gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin. J Chemother 2002, 14:618-622.
18. Chongsomchai C., Lumbiganon P., Thinkhamrop J., Ounchai J., Vudhikamraksa N. Placebo-controlled, double-blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. J Hosp Infect 2002, 52:302-306.
19. Eckenhausen F.W., Jonker P.L. Antibiotic prophylaxis in abdominal hysterectomy, with special reference to the duration of the prophylaxis. Pharm Weekbl Sci 1990, 12(6A):289-291.
20. Chang W.C., Lee M.C., Yeh L.S., Hung Y.C., Lin C.C., Lin L.Y. Quality-initiated prophylactic antibiotic use in laparoscopic-assisted vaginal hysterectomy. Aust N Z J Obstet Gynaecol 2008, 48:592-595.
21. Kocak I., Ustun C., Emre B., Uzel A. Antibiotic prophylaxis in laparoscopy. Ceska Gynekol 2005, 70:269-272.
22. Rogers R.G., Kammerer-Doak D., Olsen A., Thompson P.K., Walters M.D., Lukacz E.S., et al. A randomized, double-blind, placebo- controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress incontinence with suprapubic catheterization. Am J Obstet Gynecol 2004, 191:182-187.
23. Thinkhamrop J., Laopaiboon M., Lumbiganon P. Prophylactic antibiotics for transcervical intrauterine procedures. Cochrane Database Syst Rev 2007, Art. No.: CD005637. DOI 10.1002/14651858.CD005637.pub2.
24. Kasius J., Broekmans F., Fauser B., Devroey P., Fatemi H. Antibiotic prophylaxis for hysteroscopy evaluation of the uterine cavity. Fertil Steril 2011, 95:792-794.
25. Bhattacharya S., Parkin D.E., Reid T.M., Abramovich D.R., Mollison J., Kitchener H.C. A prospective randomized study of the effects of prophylactic antibiotics on the incidence of bacteremia following hysteroscopic surgery. Eur J Obstet Gynecol Reprod Biol 1995, 63:37-40.
26. Baggish M.S., Sze E.H. Endometrial ablation: a series of 568 patients treated over an 11-year period. Am J Obstet Gynecol 1996, 174:908-913.
27. Sawaya G.F., Grady D., Kerlikowske K., Grimes D.A. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996, 87(5 Pt 2):884-890.
28. Lavellois P., Rioux J.E. Prophylactic antibiotics for suction curettage abortion: results of a clinical controlled trial. Am J Obstet Gynecol 1988, 158:100-105.
29. Heisterberg L., Peterson K. Metronidazole prophylaxis in elective first trimester abortion. Obstet Gynecol 1985, 65:371-374.
30. Darj E., Stralin E.B., Nilsson S. The prophylactic effect of doxycycline on postoperative infection rate after first-trimester abortion. Obstet Gynecol 1987, 70:755-758.
31. Chen S., Li J., van den Hoek A. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?. Sex Transm Dis 2007, 34:230-236.
32. Larsson P.G., Platz-Christensen J.J., Dalaker K., Eriksson K., Fahraeus L., Irminger K., et al. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. Acta Obstet Gynecol Scand 2000, 79:390-396.
33. Crowley T., Low N., Turner A., Harvey I., Bidgood K., Horner P. Antibiotic prophylaxis to prevent post-abortal upper genital tract infection in women with bacterial vaginosis: randomised controlled trial. BJOG 2001, 108:396-402.
34. Prieto J.A., Eriksen N.L., Blanco J.D. A randomized trial of prophylactic doxycycline for curettage in incomplete abortion. Obstet Gynecol 1995, 85(5 Pt 1):692-696.
35. Ramin K.D., Ramin S.M., Hemsell P.G., Nobles B.J., Heard M.C., Johnson V.B., et al. Prophylactic antibiotics for suction curettage in incomplete abortion. Infect Dis Obstet Gynecol 1995, 2:213-217.
36. May W., Gulmezoglu A.M., Ba-Thike K. Antibiotics for incomplete abortion. Cochrane Database Syst Rev 2007, (4). Art. No.: CD001779. DOI: 10.1002/14651858.CD001779.pub2.
37. Lee N.C., Rubin G.L., Ory H.W., Nurkman R.T. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983, 96:119-126.
38. Farley T.M.M., Rosenberg M.J., Rowe P., Chen J.H., Meirik O. Intraterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992, 339:785-788.
39. Mishell D.R., Bell J.H., Good R.G., Moyer D.L. The intrauterine device: a bacteriologic study of the endometrial cavity. Am J Obstet Gynecol 1966, 96:119-126.
40. Grimes D.A., Lopez L.M., Schulz K.F. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999, (3). Art. No.: CD001327. DOI: 10.1002/14651858.CD001327.
41. Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections 2006, Available at, Accessed January 30, 2012. http://wwwpublichealth.gc.ca/sti.
42. Pittaway D.E., Winfield A.C., Maxson W., Daniell J., Herbert C., Wentz A.C. Prevention of acute inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis. Am J Obstet Gynecol 1983, 147:623-626.
43. Latthe P., Foon R., Toozs-Hobson P. Prophylactic antibiotics in urodynamics: a systematic review of effectiveness and safety. Neurol Urodyn 2008, 27:167-173.
44. Hooton T.M., Scholes D., Stapleton A.E., Roberts P.L., Winter C., Gupta K., et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000, 343:992-997.
45. Lower J., Burrows L., Howden N., Weber A. Prophylactic antibiotics after urodynamics in women: a decision analysis. Int Urogynecol J 2007, 18:159-164.
46. Gordon S.M. Antibiotic prophylaxis against postoperative wound infections. Cleve Clin J Med 2006, 73(1):42-45. Suppl.
47. Lee C.E., Zembower T.R., Fotis M.A., Postelnick M.J., Greenberger P.A., Peterson L.R., et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000, 160:2819-2822.
48. del Real G.A., Rose M.E., Ramirez-Atamoros M.T., Hammel J., Gordon S.M., Arroliga A.C., et al. Penicillin skin testing in patients with a history of beta- lactam allergy. Ann Allergy Asthma Immunol 2007, 98:355-359.
49. Sogn D.D., Evans R., Shepherd G.M., Casale T.B., Condemi J., Greenberger P.A., et al. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992, 152:1025.
50. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991, 337(8753):1308-1310.
51. Dash C.H. Penicillin allergy and the cephalosporins. J Antimicrob Chemother 1975, 1:107.
52. Daulat S., Solensky R., Earl H.S., Casey W., Gruchalla R.S. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol 2004, 113:1220.
53. Fonacier L., Hirschberg R., Gerson S. Adverse drug reactions to cephalosporins in hospitalized patients with a history of penicillin allergy. Allergy Asthma Proc 2005, 26:135.
54. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of Infective Endocarditis: Guidelines From the American Heart Association. Circulation 2007, 116:1736-1754.
55. Castillo E., Magee L.A., von Dadelszen P., Money D., Blonde-Hill E., van Schalkwyk J. Our patients do not need endocarditis prophylaxis for genitourinary tract procedures: insights fro the 2007 American Heart Association Guidelines. J Obstet Gynaecol Can 2008, 30:796-799.
56. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169:207-208.